Signature Biologics Expands Its Irving Footprint With a New Manufacturing and R&D Headquarters

There, Signature Biologics will manufacture perinatal-derived products that improve the body's natural healing processes in wound, musculoskeletal, and pain management applications.

Irving-headquartered Signature Biologics, which manufactures perinatal-derived products that improve the body’s natural healing processes, is growing its operations with a new 36,000-square-foot manufacturing and R&D headquarters.

The newly constructed space, also located in Irving, will feature 16,000 square feet of designated manufacturing laboratory space and 7,500 square feet of R&D space. The company said the design mirrors its transparency in business: The facility has an open floor plan and floor-to-ceiling windows into its manufacturing and R&D laboratories.

Signature Biologics’ new reasearch and development laboratory. [Photo: Signature Biologics]

Signature Biologics plans to keep its current home base as an auxiliary location. There, the team will manage product demands and train future and new employees.

“We’re excited to share this physical progress in our new facility as an outward expression of our dedication and pursuit of excellence in putting biologics to work meeting unmet clinical needs,” Founder and CEO Dr. Riordan said in a statement. “We’ve taken care to make visiting this new facility educational, transparent, and showcase our greatest asset; our brilliant employees who bring our science to the world.”

Inside the new facility

The manufacturing and R&D HQ will support Signature Biologics’ expansion across perinatal derived tissue, acellular products, and cellular products. The company aims to be the “premier, trusted source of innovative perinatal-derived therapeutic solutions.”

Signature Biologics’ manufacturing space. [Photo: Signature Biologics]

Signature Biologics preserves tissue through advanced standardized processing techniques to potentially enhance a body’s natural healing ability in wound, musculoskeletal, and pain management instances. Its process doesn’t alter the structural properties of perinatal tissue, maintaining its integrity for supplementation, reconstruction, repair, or replacement.

Its team uses its decades of experience in biologics to pioneer cellular and acellular products. They see the new facility as filling unmet clinical needs for patients across the globe.

It also includes six manufacturing ISO-7 cleanrooms, 16 ISO-5 manufacturing biosafety cabinets, three R&D cleanrooms, and six research biosafety cabinets.

Get on the list.
Dallas Innovates, every day.

Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.

One quick signup, and you’re done.
View previous emails.

R E A D   N E X T

  • These North Texas Innovators Had 'The Last Word'

    These quotable North Texans inspire, inform, motivate, or simply make us laugh. Have wise words of your own? Let us know.  You can also sign up here to get "The Last Word" in the Dallas Innovates e-newsletter each weekday. Tuesday, October 26 "I called everyone I know and told them I did not know how, but we needed to get the event to Dallas." Donna Collins-Yamini Founder/Chef/Owner Jelly Queens ...on helping to bring the World Food Championships to Dallas Nov. 5-7, via Focus Daily News. Collins-Yamini, whose Dallas-based artisan food company Jelly Queens makes jams, jellies, and sauces with uniquely…

  • dallas innovates tech and innovation news updates: what's new and next in dallas fort worth

    UT Southwestern team is awarded $8.8M grant to participate in the National Human Genome Research Institute’s IGVF Consortium; Dallas' Astrapi is awarded a U.S. Air Force AFVentures Contract; TCU Neeley Institute of Entrepreneurship wins third major GCEC award in a row; Dallas Cowboys owner Jerry Jones helps pitch Dallas as a host city of the 2026 World Cup; and more stories from around the region. Plus, you’ll find our top 10 most popular stories.

  • The eighth annual IC3 Summit will be a forum for leaders from startups to large multinationals in the biotech, pharma, healthcare, and academic communities. A key summit speaker will be Admiral Brett Giroir, M.D., the former White House COVID-19 "testing czar."

  • Veryable takes a new approach to labor: The Dallas-based tech company "variablizes" it. By connecting businesses to independent workers for manufacturing and distribution, Veryable's operations-driven approach can put people back to work and improve productivity and growth for manufacturers and suppliers.

  • The City of Irving has won silver certification from Bloomberg Philanthropies' What Works Cities—the national standard of well-managed cities recognizing the most effective use of data to inform policy and funding decisions. The honor comes in a year that's tested the mettle of municipalities nationwide. Since 2018, 40 cities have achieved the certification. This year 16 new cities were recognized, including gold-winning Austin and silver-winning San Antonio. “During the pandemic, using data to inform decision-making was more important than ever for cities," said Michael Bloomberg in a statement. “By putting data at the center of their COVID-19 response efforts, these cities saved lives and…